Department of Psychology, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana, United States of America.
Department of Biostatistics and Health Data Science, Indiana University Fairbanks School of Public Health and School of Medicine, Indianapolis, Indiana, United States of America.
PLoS One. 2023 Jan 12;18(1):e0280407. doi: 10.1371/journal.pone.0280407. eCollection 2023.
Substance use disorders (SUDs) usually involve a complex natural trajectory of recovery alternating with symptom reoccurrence. This study examined treatment course patterns over time in a community SUD clinic. We examined depressive symptoms level, primary SUD assigned at each admission, and lifetime misuse of multiple substances as potential risk factors for premature treatment termination and subsequent treatment readmission.
De-identified longitudinal data were extracted from charts of 542 patients from an SUD treatment center. Survival analysis methods were applied to predict two time-to-event outcomes: premature treatment termination and treatment readmission.
Primary opioid (vs alcohol) use disorder diagnosis at admission was associated with higher hazard of premature termination (HR = 1.91, p<0.001). The interaction between depressive symptoms level and substance use status (multiple vs single use) on treatment readmission was significant (p = 0.024), such that higher depressive symptoms level was predictive of readmission only among those with a history of single substance use (marginally significant effect). Lifetime use of multiple (vs single) substances (HR = 1.55, p = 0.002) and age (HR = 1.01, p = 0.019) predicted increased hazard of readmission.
Findings did not support a universal role for depressive symptoms level in treatment course patterns. Primary SUD diagnosis, age, and history of substance misuse can be easily assessed and incorporated into treatment planning to support SUD patients and families. This study is the first to our knowledge that afforded a stringent test of these relationships and their interactions in a time-dependent, recurrent event, competing risks survival analysis examining both termination and readmission patterns utilizing a real-world clinic-based sample.
物质使用障碍(SUD)通常涉及到一个复杂的自然康复轨迹,其间会出现症状反复。本研究在一个社区 SUD 诊所中,考察了随时间推移的治疗过程模式。我们考察了抑郁症状水平、每次入院时的主要 SUD 诊断,以及一生中滥用多种物质,这些因素可能是提前终止治疗和随后再次入院治疗的风险因素。
从一个 SUD 治疗中心的 542 名患者的图表中提取了去识别的纵向数据。应用生存分析方法预测两个时间事件结果:提前终止治疗和治疗再次入院。
入院时的主要阿片类物质(与酒精)使用障碍诊断与提前终止治疗的风险更高相关(HR=1.91,p<0.001)。抑郁症状水平与物质使用状况(多物质与单物质使用)之间的交互作用对治疗再次入院有显著影响(p=0.024),即仅在有单一物质使用史的患者中,较高的抑郁症状水平是再次入院的预测因素(边缘显著效应)。一生中使用多种(与单一)物质(HR=1.55,p=0.002)和年龄(HR=1.01,p=0.019)预测再次入院的风险增加。
研究结果不支持抑郁症状水平在治疗过程模式中普遍起作用。主要 SUD 诊断、年龄和物质滥用史可以很容易地评估,并纳入治疗计划中,以支持 SUD 患者及其家属。本研究是首次利用真实世界诊所样本,基于时间依赖、反复发生的、竞争性风险生存分析,严格检验这些关系及其相互作用,以检验终止和再次入院模式。